Location History:
- Ambler, PA (US) (2003)
- New York, NY (US) (2001 - 2010)
- Dresher, PA (US) (2005 - 2013)
Company Filing History:
16 out of 512 
5 out of 4,770 
2 out of 2,405 
Years Active: 2001-2013
Title: **Dai-Shi Su: Innovator in HIV and Cancer Research**
Introduction
Dai-Shi Su, based in Dresher, PA, is a prominent inventor with a notable portfolio of 23 patents. His innovative contributions primarily focus on compounds that play a critical role in treating HIV and cancer. Su’s work exemplifies the intersection of pharmaceuticals and advanced research, aiming to improve health outcomes for patients.
Latest Patents
Among Su's latest patents is a groundbreaking innovation concerning HIV integrase inhibitors. These compounds, referenced as Formula I, demonstrate efficacy against HIV replication and AIDS. They serve as both standalone compounds and in combination with other antiviral agents or vaccines, presenting a multifaceted approach to combatting these serious health issues. Furthermore, Su has developed processes for synthesizing epothilones and their analogues, aimed at enhancing cancer treatment options, particularly for cases with a multidrug-resistant phenotype.
Career Highlights
Dai-Shi Su has made significant strides in pharmaceutical research, with pivotal roles at notable institutions. His tenure at the Sloan-Kettering Institute for Cancer Research and Merck & Company, Inc. has provided him with robust experience in drug development and innovation. His commitment to advancing therapeutic strategies showcases his dedication to public health and scientific progress.
Collaborations
Throughout his career, Su has worked alongside esteemed researchers such as Samuel J. Danishefsky and Peter Bertinato. These collaborations have not only enriched his research but also contributed to the broader scientific community's understanding of complex medicinal chemistry.
Conclusion
Dai-Shi Su continues to push the boundaries of pharmaceutical innovation with his cumulative expertise and patented inventions. His work seeks to address critical health challenges posed by HIV and cancer, making him a noteworthy figure in the realm of medical research and invention.